WESSLING supports pharmaceutical industry customers with extensive consulting services that also include comprehensive QP services.
Our aim is to find holistic solutions to our customer's challenges and issues in the field of pharmaceutical consulting. Analytical questions concerning pharmaceutical raw materials and preparations are answered by our competent specialists in our GMP-certified laboratory. We create trust in your drugs thanks to our reliable laboratory analyses and expertise.
WESSLING also supports you with highly competent pharmaceutical consulting and analyses in maintaining and ensuring product quality and legal requirements – equating to the optimisation of your costs. If required, we can provide you with complete project support and advise you on your analytical and galenical questions.
Our services in detail
Our QP services are crucial when launching products onto the market: we provide you with experienced Qualified Persons as per Section 15 of the German Drug Act (AMG).
The services provided by the Qualified Person enable you to meet your legal obligations as a pharmaceutical company. These also include batch certification and release with QP certification. We create all GMP-relevant documents and perform 3rd party audits for our national and international customers.
Our services in detail
WESSLING supports you in finding the appropriate approval strategy and also in national and EU approval procedures (mutual recognition procedures (MRP), decentralised procedures (DCP)).
A registration dossier contains all the information required by law on a medicinal product. WESSLING takes on this task for producers of medicinal products and prepares this registration dossier. For this purpose, we compile all necessary information on the individual dossier modules in CTD format (common technical document).
We also support you in preparing registration dossiers for investigational medicinal products (IMP).
We will be happy to support you.
„Our pharmaceutical consulting is always goal-oriented: you want to launch a product onto the market, we support you with a range of services in which consulting and analysis are perfectly matched. “
If necessary, we supplement our consulting services with analytical components. Our laboratory has a manufacturing authorisation according to Section 13 AMG for the testing and approval of drugs.
Our laboratory site additionally have an EU import permit for drugs from non-EU countries. This enables us to perform approval tests with QP certification for our customers.
WESSLING offers you a full range of services from one source, also for consulting and expert reports for cosmetics.
Burkholderia ceparia complex (Bcc)
Burkholderia cepacia is a bacterial species of increasing importance for the pharmaceutical, OTC and cosmetics industries. The WESSLING experts for pharmaceutical analysis have successfully established the USP methods in their laboratory. They analyse process water, starting substances and end products for contamination with Bcc according to USP specifications.Read more
EU batch release service
The WESSLING pharmaceutical experts perform stability tests and storage on finished medicinal products, medical products with pharmaceutical content and active substances as per the current ICH and GMP specifications. We check the stability-relevant parameters, content, purity and release of active substances and prepare test plans, overview tables for stability tests and individual stability reports.Find out more
The latest equipment in our GMP-certified laboratories
In Münster, we analyse your medical products and drugs using the latest analysis technology. Would you like to find out more about the equipment at our laboratories? Here, you can find out about the laboratory analysis facilities and equipment in detail.Find out more
Laboratory analysis & consulting
WESSLING has the required GMP certificate and the narcotics permit enabling it to test cannabis flowers according to the German Pharmacopoeia as regards identity, content and purity. We use HPLC and suitable reference substances to determine the precise concentrations and components of the drug. With manufacturing authorisation according to Section 13 AMG, WESSLING also supports importers of pharmaceutical cannabis in the approval of drugs. Together with our logistics partners, we can also undertake the entire pharmaceutical service chain package.Find out more
Burkholderia ceparia complex (Bcc) 1 / 4